Apr 1986 Joined Mitsui & Co., Ltd. Jun 1991 Mitsui & Co. Italia S.p.A. Jun 1995 Mitsui & Co., Ltd., Pharma & Medical Business Office, Life Science Division Feb 2003 Mitsui & Co. Deutschland GmbH, General Manager, Specialty Chemicals Department Dec 2006 Seconded to the Company as Director and Manager, Corporate Planning Office Jul 2008 Mitsui & Co., Ltd., General Manager, European Business Office, Agri-Science Division Jul 2011 Mitsui & Co., Ltd., General Manager, Medical & Healthcare Business Department II, Consumer Service Business Division Jul 2017 Mitsui & Co. (U.S.A.), Inc., SVP and General Manager, Consumer Service Business Products Division, Americas Oct 2019 Joined the Company as Executive Vice President and COO, General Manager of R&D Division Oct 2019 President and General Manager of R&D Division Dec 2019 Representative Director, President and General Manager of R&D Division Jan 2021 Director, OLIC (Thailand) Limited Oct 2024 Representative Director, Chairman (current)

Apr 1998 Joined Fujisawa Pharmaceutical Co., Ltd. (now Sanofi K.K.) Jun 2003 Joined GlaxoSmithKline K.K. Jul 2009 Joined Meiyu Kogyo Co., Ltd. Sep 2010 Joined the Company Oct 2016 Executive Officer, General Manager of Sales Department Oct 2018 General Manager of Sales Division Oct 2019 General Manager of Sales Division and General Manager of Sales Planning Department Oct 2021 Managing Executive Officer, General Manager of SCM Department Oct 2023 General Manager of Corporate Planning Department Dec 2023 Director Oct 2024 Representative Director, President (current) Jan 2025 Director, OLIC (Thailand) Limited (current)

Apr 1987 Joined Nomura Trading Co., Ltd. Apr 2000 Joined the Company Oct 2000 Manager, Corporate Planning Office Dec 2003 Director Oct 2006 Manager, General Affairs Department Oct 2010 General Manager, General Affairs Department Oct 2012 Director, OLIC (Thailand) Limited Oct 2013 Seconded to OLIC (Thailand) Limited as Managing Director Mar 2015 Executive Officer Oct 2016 Managing Executive Officer Oct 2017 General Manager of Corporate Division and General Manager of Corporate Planning Department Dec 2017 Director (current) Oct 2019 General Manager of Corporate Management Department Oct 2020 General Manager of SCM Department Oct 2021 Executive Vice President, General Manager of Toyama Plant Nov 2021 Director, OLIC (Thailand) Limited (current) Oct 2025 Executive Vice President, General Manager of Corporate Management Division (current)

Apr 1989 Joined Eisai Co., Ltd. Apr 2002 Director of Europe, Eisai Ltd. (now Eisai Europe Ltd.) Jun 2004 President and General Manager, Eisai S.A.S. Jun 2010 Head of Strategic Planning, Asia Business, Eisai China Pharmaceutical Co., Ltd. Apr 2011 Deputy General Manager, Eisai China Pharmaceutical Co., Ltd.; General Manager, Eisai (Suzhou) Trading Co., Ltd. Oct 2012 General Manager, Global Planning Department, Eisai Co., Ltd. Dec 2012 General Manager, Talent Management Department, Human Resources Division, Eisai Co., Ltd. Jul 2013 Joined Iromu Pharmaceutical Co., Ltd. (now NeoCritica Pharmaceutical Co., Ltd.) Jan 2014 Representative Director, Iromu Pharmaceutical Co., Ltd. Apr 2014 Representative Director, YL Biologics Co., Ltd. Mar 2016 Joined Santen Pharmaceutical Co., Ltd.; Executive Officer, General Manager of Asia Business Division Apr 2017 Executive Officer, General Manager of Planning Division, Santen Pharmaceutical Co., Ltd. Oct 2017 Managing Executive Officer, General Manager of Planning Division, Santen Pharmaceutical Co., Ltd. Aug 2022 Joined the Company as Executive Vice President and General Manager of Corporate Strategy Division (current) Dec 2022 Director (current) Jan 2025 Director, OLIC (Thailand) Limited (current)

Apr 1972 Joined Kyorin Pharmaceutical Co., Ltd. Jun 2002 Director, Head of Drug Discovery Research, Kyorin Pharmaceutical Co., Ltd. Dec 2004 Director, ActivX Biosciences, Inc. (San Diego) Jun 2005 Director, Managing Executive Officer, Head of Drug Discovery Research, Kyorin Pharmaceutical Co., Ltd. Jan 2006 Director, Responsible for Intellectual Property, Kyorin Co., Ltd. Jun 2007 Director, Senior Managing Executive Officer, Responsible for Intellectual Property, Kyorin Co., Ltd.; Director, Senior Managing Executive Officer, Head of Research Division, Responsible for Intellectual Property, Kyorin Pharmaceutical Co., Ltd. Jun 2008 Director, Senior Managing Executive Officer, Responsible for Research, Development and Intellectual Property, Kyorin Co., Ltd.; Director, Senior Managing Executive Officer, Head of Research Division, Responsible for Development Division and Intellectual Property, Kyorin Pharmaceutical Co., Ltd. Jun 2009 Director, Kyorin Co., Ltd.; Representative Director, President, Head of Research and Development Division, Responsible for Business Development Department, Kyorin Pharmaceutical Co., Ltd. Jun 2012 Director and Senior Advisor, Kyorin Pharmaceutical Co., Ltd. Jun 2013 Senior Advisor, Kyorin Pharmaceutical Co., Ltd. Dec 2016 Outside Director of the Company (current) Jan 2018 Outside Director, Trans Chromosomics, Inc. Jun 2018 Program Officer, Program for Innovative Drug Development for Emerging and Re-emerging Infectious Diseases, Japan Agency for Medical Research and Development (AMED) (current) May 2019 Project Evaluation Committee Member, AMED Nov 2022 Visiting Professor, Omura Satoshi Memorial Institute, Kitasato University (current) Jun 2023 Visiting Professor, Organization for Research Promotion and Social Partnership, University of Yamanashi (current) Jun 2024 Chief Advisor, Omura Memorial Microbial Resources Research Frontier Programme, University of Yamanashi (current)

Apr 1982 Joined Sankosha Co., Ltd., Trade Department May 1986 Joined Kosan Boeki Co., Ltd. May 1992 Joined Uniscope Co., Ltd. (now Uniscope R&D Co., Ltd.) May 1993 Joined Global Link Management Inc. May 1994 Co-founder, Japan Emergency NGO (JEN); Regional Representative, Former Yugoslavia Programme Apr 2000 Board Member, JEN Jul 2000 Board Member and Secretary General, JEN Apr 2007 Board Member, Specified Nonprofit Corporation Akarui Shakai Zukuri Undo Jun 2007 Board Member, Japan NGO Center for International Cooperation Apr 2011 Co-Representative Director and Board Member, Japan Platform Feb 2014 Councillor, Education Support Global Fund (now Public Interest Incorporated Foundation Education Support Global Fund) Apr 2016 Co-Representative Director, JEN; Councillor, NHK International Broadcasting Programme Deliberation Committee May 2016 Board Member, Rikkyo School in Japan Sep 2016 Advisor, UN Central Emergency Response Fund Sep 2018 Board Member and Secretary General, JEN (current) Jun 2020 Director, Education Support Global Fund (now Public Interest Incorporated Foundation Education Support Global Fund) Dec 2020 Outside Director of the Company (current) Jun 2025 Auditor, General Incorporated Association Institute for the Fusion of Eastern and Western Knowledge (current)

Apr 1984 Joined The Taiyo Kobe Bank, Ltd. (now Sumitomo Mitsui Banking Corporation) Aug 1994 Chief Dealer of Spot USD/JPY Desk, Foreign Exchange Funds Department (Tokyo), Sakura Bank, Ltd. (now Sumitomo Mitsui Banking Corporation) (in charge of Bank of Japan) Jan 1995 Member, Tokyo Foreign Exchange Market Practice Committee (now Tokyo Foreign Exchange Market Committee) Jul 1997 Head of Option Desk (Joint Head of Trading Group), Foreign Exchange Funds Department (London), Sakura Bank, Ltd. Oct 1997 Head of Trading Group, Investment Banking DC Market Sales Department (London), Sakura Bank, Ltd. Apr 2001 Head of Trading Group, Market Sales Department (London), Sumitomo Mitsui Banking Corporation Jul 2003 Senior Deputy General Manager, Consulting Business Division, Sumitomo Mitsui Banking Corporation Oct 2003 Senior Deputy General Manager, Private Banking Sales Department, Sumitomo Mitsui Banking Corporation Jan 2004 Senior Private Banker and Senior Promotion Manager, Private Banking Sales Department, Sumitomo Mitsui Banking Corporation Jul 2005 Opened Ozawa Legal Office, Certified Administrative Procedures Legal Specialist (current) Nov 2007 Joined UBS Wealth Management (UBS AG Tokyo Branch), Director, Desk Head Sep 2010 Joined FJ Planning Co., Ltd. (now FJP Co., Ltd.); Representative Director, President (current) Jan 2011 Established Value Create Partners Co., Ltd.; Representative Director, President (current) Apr 2012 Regular Member, Cosmos Adult Guardianship Support Center (now Public Interest Incorporated Foundation Cosmos Adult Guardianship Support Center) (current) Oct 2017 Executive Partner, Takuwa (Japan) Co., Ltd. Dec 2019 Joined Imai Seiichi Memorial Foundation as Managing Director and Secretary General (current) Mar 2020 Joined Image Plan Co., Ltd.; Representative Director, President (current) Dec 2024 Outside Director of the Company (current)

Apr 1986 Joined Daiwa Securities Co., Ltd. Apr 2010 Representative Director, President, Daiwa Quantum Capital Co., Ltd. Apr 2013 Director, Daiwa PI Partners Co., Ltd. Apr 2014 Director, Daiwa Corporate Investment Co., Ltd. Apr 2020 Representative Director, President, Daiwa Corporate Investment Co., Ltd. Oct 2024 Advisor, Link Partners Law Office (current) Dec 2025 Outside Director of the Company (current)

Mar 2002 Passed National Medical Licensing Examination May 2002 Worked at general hospital; regular outpatient psychosomatic medicine practice at general hospital; company physician, Furukawa Electric Co., Ltd. Mar 2010 Obtained Doctor of Medicine degree Apr 2011 Company Physician, Maruij Group Inc. (current) Apr 2014 General Manager, Health Promotion Department, Maruij Group Inc. Apr 2019 Executive Officer, Maruij Group Inc. Apr 2020 Executive Officer, General Manager of Wellness Promotion Department, Maruij Group Inc. May 2021 Executive Officer, CWO (Chief Well-being Officer), General Manager of Wellness Promotion Department, Maruij Group Inc. Jun 2021 Director and Executive Officer, CWO, General Manager of Wellness Promotion Department, Maruij Group Inc. Apr 2022 Director and Executive Officer, CWO, General Manager of Well-being Promotion Department, Maruij Group Inc. Apr 2023 Director and Senior Executive Officer, CWO, General Manager of Well-being Promotion Department, Maruij Group Inc. (current) Dec 2025 Outside Director of the Company (current)

Apr 1987 Joined Hokuriku Bank, Ltd. Jan 2006 Deputy General Manager, Shinjuku Branch, Hokuriku Bank, Ltd. Jun 2007 Branch Manager, Katsuyama Branch, Hokuriku Bank, Ltd. Jan 2009 Deputy General Manager, Takaoka Branch, Hokuriku Bank, Ltd. Sep 2010 Branch Manager, Kanazawa Ekimae Branch, Hokuriku Bank, Ltd. Apr 2013 Branch Manager, Fukumitsu Branch, Hokuriku Bank, Ltd. Jan 2015 General Manager, Retail Promotion Office, Sales Promotion Department, Hokuriku Bank, Ltd. Jun 2016 Deputy General Manager, Retail Promotion Department, Hokuriku Bank, Ltd. Jan 2017 Branch Manager, Takaoka Hirokoji Branch, Hokuriku Bank, Ltd. Jun 2019 Deputy General Manager, Regional Revitalization Department, Hokuriku Bank, Ltd. Jun 2020 General Manager, Regional Revitalization Department, Hokuriku Bank, Ltd. Aug 2021 Joined Toa Pharmaceutical Co., Ltd.; General Affairs Manager, General Affairs Department, Management Division Oct 2021 General Manager, General Affairs Department, Management Division, Toa Pharmaceutical Co., Ltd. Oct 2023 Joined the Company Dec 2023 Full-time Corporate Auditor (current)

Apr 1987 Registered with Tokyo Bar Association Jan 1991 Opened Mimura Fujiaki Law Office Jun 2002 Opened Sakai Mimura Law Office (later Bingham Sakai Mimura Aizawa Foreign Law Joint Enterprise) Dec 2003 Outside Corporate Auditor of the Company (current) May 2009 Outside Corporate Auditor, Fuji Electronics Co., Ltd. Apr 2015 Outside Corporate Auditor, Macnica Fuji Electronics Holdings, Inc. (now Macnica Holdings, Inc.) Apr 2015 Partner, Anderson Mori & Tomotsune Sep 2018 Outside Corporate Auditor, SANKO MARKETING FOODS Co., Ltd. (formerly Sanko Marketing Foods Co., Ltd.) (current) Jan 2025 Advisor, Anderson Mori & Tomotsune Foreign Law Joint Enterprise (current)

Apr 1992 Joined Sumitomo Corporation 1995 Dispatched registrant, Mitsubishi Corporation 1999 Joined Kōgin Securities Co., Ltd. (now Mizuho Securities Co., Ltd.) Aug 2003 Joined Leox Co., Ltd. (now Leox Capital Works Co., Ltd.) 2004 Executive Officer of the same company Aug 2007 Director and Representative, Tokyo Branch, Export Japan Co., Ltd. Jul 2010 Founder and Representative Director, Baobab Co., Ltd. (current) Apr 2011 Joined National Institute of Information and Communications Technology Dec 2019 Outside Corporate Auditor of the Company (current)